Table 4.
Prevalence of MUCH defined by daytime ABPM stratified by clinic BP
| Clinic systolic BP (mmHg) | Baseline visit | Return visit at 4 weeks | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CH (n) | UCH (n) | MUCH (%) | OR (95% CI) | aOR | CH (n) | UCH (n) | MUCH (%) | OR | aOR | |
| <110 | 66 | 1 | 1.5 | 1 | 1 | 62 | 3 | 4.6 | 1 | 1 |
| 110–119 | 69 | 14 | 16.9 | 13.4 (1.7–104.7) | 9.1 (1.1–74.9) | 53 | 11 | 17.2 | 4.3 (1.1–16.2) | 4.9 (1.1–21.2) |
| 120–129 | 39 | 20 | 33.9 | 33.8 (4.4–262.1) | 21.2 (2.6–172.1) | 43 | 29 | 40.3 | 13.9 (4.0–48.7) | 17.1 (4.1–70.9) |
| 130–139 | 18 | 35 | 66.0 | 128.3 (16.4–1001.8) | 90.3 (11.1–734.3) | 19 | 26 | 57.8 | 28.3 (7.7–103.9) | 43.9 (9.6–201.7) |
aOR, adjusted odds ratio; OR, odds ratio.
Adjustments were for age, diabetes, smoking, cardiovascular disease, number of antihypertensive drugs, eGFR, and log urinary albumin/creatinine ratio.